ADAR1 Capital Management »

First Tracks Biotherapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4M 72k 20.12

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Anteris Technologies Global (AVR)
Editas Medicine (EDIT)
Denali Therapeutics (DNLI)
Spyre Therapeutics Com New (SYRE)

View all positions for ADAR1 Capital Management

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics